Remdesivir (Veklury®): PRAC checks signal for kidney damage
2020.10.06
Active substance: remdesivir
EMA’s safety committee (PRAC) has started a review of a safety signal to assess reports of acute kidney injury in some patients with COVID-19 taking Veklury (remdesivir).